Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has become one of the most studied weight loss medications in modern medicine. Clinical trials demonstrate that patients lose between 10-15% of their starting body weight on average, with some individuals achieving losses exceeding 20%. Your actual weight loss depends on multiple factors including your genetic makeup, adherence to the medication regimen, dietary choices, and physical activity level.

Average Weight Loss Results from Semaglutide Trials

The STEP clinical trial program, which evaluated semaglutide for chronic weight management, followed nearly 4,600 adults with obesity or overweight. Over 68 weeks of treatment, participants receiving the highest dose of semaglutide lost an average of 15.3% of their starting body weight, compared to 2.6% in the placebo group. This difference of roughly 12.7 percentage points represents clinically meaningful weight reduction that translates to improved cardiovascular health markers and reduced disease risk.

Not all patients achieve identical results—the range spans from modest losses of 5% to remarkable reductions of 25% or more. Weight loss typically accelerates during the first 12-16 weeks as your body adjusts to the medication, then continues at a slower but steady pace through months 6-12. Individual response depends partly on your genetic predisposition to GLP-1 signaling, which PlexusDx can assess through the Precision Peptide Genetic Test to help predict your likely response pattern.

Most weight loss occurs in the first 6 months of treatment, with a plateau phase often appearing around month 12. Continued adherence to semaglutide typically maintains the achieved weight loss, preventing the rapid regain often seen after weight loss through diet alone.

Why Individual Weight Loss Varies with Semaglutide

Your genetic variants in the GLP1R gene (including rs6923761) influence how strongly your appetite-control centers respond to the medication. Some people carry genetic variations that enhance GLP-1 signaling, predisposing them to greater appetite suppression and faster weight loss. Others have genetic patterns that require higher doses or combination therapy to achieve equivalent results, which is why personalized genetic testing before starting treatment can inform your treatment strategy.

Baseline metabolic rate, starting body weight, and insulin resistance each affect weight loss speed and total amount lost. Patients with insulin resistance often see accelerated initial weight loss as semaglutide improves insulin sensitivity, which can trigger additional metabolic changes. Lifestyle factors—including meal composition, meal timing, physical activity frequency, and sleep quality—modulate the medication's effects and should be optimized alongside pharmacotherapy.

Dose escalation also impacts outcomes: while some patients achieve significant weight loss at lower doses, others require higher doses to access the full medication effect. PlexusDx delivers semaglutide injections starting at $149/month flat, meaning your dose may need to go up, but your price won't—allowing dose optimization without financial barriers.

Timeline for Weight Loss with Semaglutide Injection

Weeks 1-4 mark the initiation phase, during which most patients begin at a low starting dose to minimize gastrointestinal side effects. Weight loss during this period is typically minimal, often 1-3 pounds, as your body adjusts to the medication's appetite-suppressing signals. Many patients report reduced food cravings and earlier satiety starting within days, though the scale may not move significantly in week one.

Weeks 5-12 represent the acceleration phase, where dose increases occur and weight loss momentum builds. Patients commonly report 1-2 pounds of weight loss per week during this window, driven by sustained appetite suppression and reduced calorie intake. Some patients experience minor gastrointestinal effects like mild nausea during dose escalation, which typically resolves within a few days as the body acclimates.

Months 4-6 show continued steady weight loss, often averaging 2-4 pounds weekly for patients adhering to medication and lifestyle modifications. By month 6, most patients have lost 8-12% of their starting body weight. Months 7-12 show a gradual deceleration in weight loss rate as your body reaches a new metabolic equilibrium, though continued slow loss typically continues if medication is maintained.

Factors That Support Maximum Weight Loss with Semaglutide

Consistent medication adherence is foundational—missing doses or irregular injection schedules reduces the sustained GLP-1 signaling necessary for appetite control and metabolic benefits. Weekly semaglutide injections are designed to maintain steady medication levels, so maintaining your injection schedule directly correlates with weight loss consistency. PlexusDx ships medications directly to your home, eliminating pharmacy visits and supporting adherence through convenient weekly administration.

Protein intake during weight loss preserves muscle mass, which maintains metabolic rate and prevents the metabolic slowdown common in diet-only weight loss. Aiming for 25-30% of calories from protein, combined with whole foods and adequate fiber intake, amplifies semaglutide's appetite-suppressing effects. Adequate hydration and regular physical activity—even moderate walking—further enhance weight loss and cardiovascular benefits beyond medication alone.

Sleep quality and stress management influence appetite-regulating hormones that interact with GLP-1 signaling pathways. Adults sleeping fewer than 6 hours nightly show reduced weight loss on semaglutide compared to those sleeping 7-9 hours, suggesting that sleep optimization should accompany medication therapy. The Precision Peptide Genetic Test identifies your genetic predispositions across appetite, energy expenditure, and fat storage pathways, enabling personalized recommendations for diet composition and activity level that maximize your individual response.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose in my first month on semaglutide?

First-month weight loss typically ranges from 2-8 pounds, depending on starting dose and individual metabolism. Most of this loss comes from appetite suppression leading to reduced calorie intake, with initial water weight loss also contributing. Weight loss accelerates in months 2-3 as your dose increases and your body fully adjusts to the medi...

Is 15% weight loss realistic for most people?

Yes—the STEP clinical trials showed that 75% of semaglutide users achieved at least 10% weight loss, and 50% reached 15% or more. Achieving these results requires consistent medication use, attention to nutrition and activity, and patience with the timeline, which typically spans 6-12 months for significant loss.

Can I lose 50+ pounds on semaglutide?

Significant weight losses of 50+ pounds are possible, particularly for individuals with substantial starting body weight and strong adherence to medication and lifestyle modifications. Results exceeding 20% total body weight loss typically require 12+ months of consistent treatment and often benefit from combination therapy like GLP-Squared, whi...

What happens to weight loss if I stop taking semaglutide?

Weight regain typically begins within weeks of stopping semaglutide, with most patients returning to their pre-treatment weight over 12 months if lifestyle factors remain unchanged. This reflects the chronic nature of obesity—medication controls the biological drive to regain weight, which is why ongoing treatment is often necessary for sustaine...

Does genetic testing predict how much weight I'll lose?

PlexusDx's Precision Peptide Genetic Test analyzes your GLP1R, GIPR, FTO, and MC4R variants to predict your genetic predisposition for GLP-1 response and appetite control. While genetics don't determine absolute weight loss amounts, they identify which patients likely benefit from dose optimization, combination therapy, or enhanced lifestyle sup...

How much does semaglutide cost at PlexusDx?

Compounded semaglutide injections start at $149/month flat across all commitment tiers—your dose may need to go up, but your price won't. PlexusDx serves all 50 states without requiring insurance, memberships, or hidden fees, with HSA/FSA eligibility available.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves